✦ LIBER ✦

A 12-month comparative trial of auranofin and d-penicillamine in rheumatoid arthritis

✍ Scribed by Derrick D. Felix-Daves; Alison M. Stewart; Brian R. Wilkinson; John R. Bateman; John P. Delamere

Book ID: 115679504
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 341 KB
Volume: 75
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(83)90487-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative trial of Timegadine and D-

A comparative trial of Timegadine and D-penicillamine in rheumatoid arthritis

✍ J. M. Mbuyi-Muamba; J. Dequeker 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 330 KB

CONTROLLED TRIAL OF D(-)PENICILLAMINE IN

CONTROLLED TRIAL OF D(-)PENICILLAMINE IN SEVERE RHEUMATOID ARTHRITIS

✍ Multicentre Trial Group, 📂 Article 📅 1973 🏛 The Lancet 🌐 English ⚖ 742 KB

Auranofin and D-penicillamine: a one yea

Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin

✍ Franchimont, P.; Hauwaert, C.; Vanschoubroek, K. 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 946 KB

Clinical Trial of Penicillamine in Rheum

Clinical Trial of Penicillamine in Rheumatoid Arthritis

✍ Norman O. Rothermich; Marvin H. Thomas; Vol K. Phillips; Waldemar Bergen 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

## Abstract The medical records of our first 200 consecutive rheumatoid arthritis patients treated with penicillamine were analyzed retrospectively. All but 5 patients (97.5%) had undergone earlier chrysotherapy that resulted in either therapeutic failure or toxicity. Only 57 patients (28.5%) were

Controlled multicenter trial of tioproni

Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis

✍ Giampiero Pasero; Pietro Pellegrini; Umberto Ambanelli; Maria Laura Ciompi; Vinc 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

## Abstract Fifty‐seven patients took part in a controlled double‐blind trial between tiopronin and D‐penicillamine as basic treatment for rheumatoid arthritis. Thirty‐nine (19 receiving tiopronin, 20 receiving D‐penicillamine) completed the trial after 1 year. Both drugs resulted in a decrease of

D-penicillamine in the treatment of rheu

D-penicillamine in the treatment of rheumatoid arthritis

✍ Ian K. Tsang; Caroline A. Patterson; Howard B. Stein; Harold S. Robinson; Denys 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 3 views